Similar articles for PMID: 30672150

Year	Number of Results
1995	1
1996	2
1997	2
1998	1
2001	2
2002	1
2003	2
2004	2
2005	1
2006	2
2008	1
2009	2
2010	1
2011	6
2013	3
2014	3
2015	11
2016	10
2017	12
2018	15
2019	12
2020	4
2021	5
2022	4
2023	3
2024	0

1

Safe Nanocomposite-Mediated Efficient Delivery of MicroRNA Plasmids for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Therapy.

Tsai YC, Teng IL, Jiang ST, Lee YC, Chiou YY, Cheng FY. Tsai YC, et al. Adv Healthc Mater. 2019 Mar;8(5):e1801358. doi: 10.1002/adhm.201801358. Epub 2019 Jan 23. Adv Healthc Mater. 2019. PMID: 30672150

2

CD8⁺ T cells modulate autosomal dominant polycystic kidney disease progression.

Kleczko EK, Marsh KH, Tyler LC, Furgeson SB, Bullock BL, Altmann CJ, Miyazaki M, Gitomer BY, Harris PC, Weiser-Evans MCM, Chonchol MB, Clambey ET, Nemenoff RA, Hopp K. Kleczko EK, et al. Kidney Int. 2018 Dec;94(6):1127-1140. doi: 10.1016/j.kint.2018.06.025. Epub 2018 Sep 21. Kidney Int. 2018. PMID: 30249452 Free PMC article.

3

microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism.

Hajarnis S, Lakhia R, Yheskel M, Williams D, Sorourian M, Liu X, Aboudehen K, Zhang S, Kersjes K, Galasso R, Li J, Kaimal V, Lockton S, Davis S, Flaten A, Johnson JA, Holland WL, Kusminski CM, Scherer PE, Harris PC, Trudel M, Wallace DP, Igarashi P, Lee EC, Androsavich JR, Patel V. Hajarnis S, et al. Nat Commun. 2017 Feb 16;8:14395. doi: 10.1038/ncomms14395. Nat Commun. 2017. PMID: 28205547 Free PMC article.

4

Therapeutic microRNAs in polycystic kidney disease.

Yheskel M, Patel V. Yheskel M, et al. Curr Opin Nephrol Hypertens. 2017 Jul;26(4):282-289. doi: 10.1097/MNH.0000000000000333. Curr Opin Nephrol Hypertens. 2017. PMID: 28399020 Free PMC article. Review.

5

Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline.

Ben-Dov IZ, Tan YC, Morozov P, Wilson PD, Rennert H, Blumenfeld JD, Tuschl T. Ben-Dov IZ, et al. PLoS One. 2014 Jan 29;9(1):e86856. doi: 10.1371/journal.pone.0086856. eCollection 2014. PLoS One. 2014. PMID: 24489795 Free PMC article. Clinical Trial.

6

Inhibition of MiR-199a-5p reduced cell proliferation in autosomal dominant polycystic kidney disease through targeting CDKN1C.

Sun L, Zhu J, Wu M, Sun H, Zhou C, Fu L, Xu C, Mei C. Sun L, et al. Med Sci Monit. 2015 Jan 15;21:195-200. doi: 10.12659/MSM.892141. Med Sci Monit. 2015. PMID: 25588980 Free PMC article.

7

Outcomes of patients with autosomal-dominant polycystic kidney disease on peritoneal dialysis: A meta-analysis.

Boonpheng B, Thongprayoon C, Wijarnpreecha K, Medaura J, Chebib FT, Cheungpasitporn W. Boonpheng B, et al. Nephrology (Carlton). 2019 Jun;24(6):638-646. doi: 10.1111/nep.13431. Epub 2019 Apr 23. Nephrology (Carlton). 2019. PMID: 29952039

8

Autosomal dominant polycystic kidney disease: pathophysiology and treatment.

McCarthy S, McMullen M. McCarthy S, et al. ANNA J. 1997 Feb;24(1):45-51; quiz 52-3. ANNA J. 1997. PMID: 9146123 Review.

9

Nutraceutical for Autosomal Dominant Polycystic Kidney Disease Therapy.

Yuajit C, Chatsudthipong V. Yuajit C, et al. J Med Assoc Thai. 2016 Jan;99 Suppl 1:S97-103. J Med Assoc Thai. 2016. PMID: 26817244 Review.

10

Anti-microRNA screen uncovers miR-17 family within miR-17~92 cluster as the primary driver of kidney cyst growth.

Yheskel M, Lakhia R, Cobo-Stark P, Flaten A, Patel V. Yheskel M, et al. Sci Rep. 2019 Feb 13;9(1):1920. doi: 10.1038/s41598-019-38566-y. Sci Rep. 2019. PMID: 30760828 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year